LGVN Earnings — Longeveron Inc. Common Stock Post-ER Performance | BigEarnings
LGVN — Longeveron Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$0.81
Market Cap$25.0M
P/E—
52W Range$0.47 – $1.80
Next Earnings2026-08-12
About Longeveron Inc. Common Stock
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.